Loading company…
Pharmathene develops biopharmaceuticals and medical countermeasures for public health and biodefense needs.
Founded in 2001 and based in Annapolis, US, Pharmathene develops and commercializes vaccines, therapeutics, and other medical countermeasures for infectious diseases and biodefense. Its customers include government agencies and private sector partners. A PIPE round raised USD 19.30 mn from investors including Baker Brothers Investments and Ontario Teachers' Pension Plan.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in